Type of Posting: Publication Announcement
Posting Date: 22–Feb–2023
The revisions proposed in PF 47(6) for Mesalamine Extended-Release Capsules were approved by the Expert Committee and were scheduled to be published as part of USP-NF 2023, Issue 2 on February 1 with a planned official date of August 1, 2023.
USP expects to publish these revisions on February 24, 2023, with an official date of August 24, 2023. The updated official date has been approved by the Expert Committee.
When searching the USP–NF Online platform, this file will be available under the monthly publication date (February 24, 2023) search facet.
Should you have any questions, please contact Documentary Standards Support (stdsmonographs@usp.org).
CN-23-031-00